Elisa Rauseo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elisa Rauseo has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Steffen Ellebaek Petersen
Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, W Smithfield, London EC1A 7BE, UK
8 shared publications - Nay Aung
Queen Mary University of London
7 shared publications - Ahmed M. Salih
William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK; Department of Population Health Sciences, University of Leicester, Leicester, United Kingdom; Department of Computer Science, Faculty of Science, University of Zakho, Zakho, Kurdistan, Iraq; Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, West Smithfield, London, EC1A 7BE, UK
4 shared publications Jackie Cooper
William Harvey Research Institute, NIHR Barts Biomedical Research Centre (E.R., A.M.S., J.C., M.A., S.C., H.N., P.B.M., N.A., S.E.P.), Queen Mary University London, Charterhouse Square, United Kingdom
4 shared publications- Anthony Mathur
Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London
3 shared publications Gregory G. Slabaugh
Digital Environment Research Institute, Queen Mary University of London, United Kingdom; School of Electronic Eng. & Computer Science, Queen Mary University of London, United Kingdom; Alan Turing Institute, The British Library, John Dodson House, London, United Kingdom
3 shared publications
Latest Publications
- Open Access
- 17 July 2026
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- p. 102776
Advancing Heart Ageing in Ischemic Heart Disease: Insights from CMR and ECG Analysis
- 17 July 2026
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- p. 102776
Open AccessAdvancing Heart Ageing in Ischemic Heart Disease: Insights from CMR and ECG Analysis
- Top Cited PapersOpen Access
- 1 June 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (6) , e25187
Clinical Phenotypes in Hypertension: A Data-Driven Approach to Risk Stratification
BACKGROUND: Hypertension is a major contributor to cardiovascular morbidity and mortality. Its heterogeneity complicates risk stratification. Unsupervised machine learning can uncover risk profiles and refine preventative strategies. This study applied a data-driven approach to identify clinical phenotypes of hypertension, examine their associations with cardiovascular imaging characteristics and adverse outcomes, and assess the mediating role of cardiac imaging features in these associations. METHODS: Fourteen thousand eight hundred forty UK Biobank participants with diagnosed hypertension and cardiovascular magnetic resonance imaging were analyzed. K-means clustering was applied to 77 clinical variables. Associations with incident heart failure, atrial fibrillation, atherosclerotic events, all-cause mortality, and major adverse cardiovascular events were examined and adjusted for cardiovascular risk factors. Mediation analyses assessed the role of cardiovascular imaging features in the association between clusters and outcomes. RESULTS: Three clusters emerged. Cluster 1, predominantly female with the most favorable metabolic profile, had the lowest risk. Cluster 2, predominantly male with the highest atherosclerosis burden, carried the greatest risk for all adverse events, independent of cardiovascular risk factors. They showed severe cardiac remodeling, impaired cardiac mechanisms, and global left atrial dysfunction. Cluster 3 had a profile resembling metabolic syndrome, with moderate risk for atrial fibrillation and all-cause death (hazard ratio, 1.65 and 1.58; P <0.05). Although in cluster 2 the risk was largely mediated by left ventricular hypertrophy, in cluster 3 its role was attenuated and more evenly balanced with left atrial dysfunction. CONCLUSIONS: Clustering analysis identified distinct hypertension phenotypes with specific risk profiles, suggesting potential for improved stratification and more tailored treatment approaches.
- 1 June 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (6) , e25187
Top Cited PapersOpen AccessClinical Phenotypes in Hypertension: A Data-Driven Approach to Risk Stratification
BACKGROUND: Hypertension is a major contributor to cardiovascular morbidity and mortality. Its heterogeneity complicates risk stratification. Unsupervised machine learning can uncover risk profiles and refine preventative strategies. This study applied a data-driven approach to identify clinical phenotypes of hypertension, examine their associations with cardiovascular imaging characteristics and adverse outcomes, and assess the mediating role of cardiac imaging features in these associations. METHODS: Fourteen thousand eight hundred forty UK Biobank participants with diagnosed hypertension and cardiovascular magnetic resonance imaging were analyzed. K-means clustering was applied to 77 clinical variables. Associations with incident heart failure, atrial fibrillation, atherosclerotic events, all-cause mortality, and major adverse cardiovascular events were examined and adjusted for cardiovascular risk factors. Mediation analyses assessed the role of cardiovascular imaging features in the association between clusters and outcomes. RESULTS: Three clusters emerged. Cluster 1, predominantly female with the most favorable metabolic profile, had the lowest risk. Cluster 2, predominantly male with the highest atherosclerosis burden, carried the greatest risk for all adverse events, independent of cardiovascular risk factors. They showed severe cardiac remodeling, impaired cardiac mechanisms, and global left atrial dysfunction. Cluster 3 had a profile resembling metabolic syndrome, with moderate risk for atrial fibrillation and all-cause death (hazard ratio, 1.65 and 1.58; P <0.05). Although in cluster 2 the risk was largely mediated by left ventricular hypertrophy, in cluster 3 its role was attenuated and more evenly balanced with left atrial dysfunction. CONCLUSIONS: Clustering analysis identified distinct hypertension phenotypes with specific risk profiles, suggesting potential for improved stratification and more tailored treatment approaches.
- 1 May 2026
- Published by Springer Nature
- p. 203-213
Construction of a Bi-Atrial Statistical Shape Atlas for In-Silico Population Studies
- 1 May 2026
- Published by Springer Nature
- p. 203-213
Construction of a Bi-Atrial Statistical Shape Atlas for In-Silico Population Studies
- Open Access
- 27 January 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 7 (2)
Understanding the mechanisms of TAVI durability through computational modelling: a multidisciplinary review
As transcatheter aortic valve implantation (TAVI) expands to younger populations, durability has become a concern, requiring a lifetime rather than a single-procedure perspective. While clinical trials suggest comparable mid-term performance to surgical bioprostheses, data beyond 10 years remain limited, particularly for bicuspid valves, valve-in-valve procedures, and complex anatomies. Computational modelling combines patient anatomy and device design in computer-based simulations to study valve performance under physiological loading. Applied to TAVI, these models can reproduce implantation, evaluate mechanical stresses, and simulate blood flow, providing mechanistic insights into deterioration processes, including altered leaflet loading, stent deformation, and thrombosis-prone flow. Although these simulations do not directly assess durability, they use surrogate metrics linked with these mechanisms, helping identify factors that may influence longevity and guide design and procedural refinements. Clinically, modelling could support patient-specific planning and reintervention strategies, informing decisions across the valve-replacement pathway, an important consideration as younger patients are likely to undergo multiple lifetime procedures. Integrating these tools into pre-procedural planning may help anticipate challenges such as coronary access, annular geometry, and redo feasibility. However, current studies report elements of verification and field-level validation, but none complete a pre-specified, calibrated surrogate-to-outcome validation with uncertainty/sensitivity analysis; thus, durability predictions remain exploratory. Progress needs transparent verification, field checks vs. bench or imaging, surrogate calibration to data, outcome testing in independent cohorts, and routine uncertainty/sensitivity reporting, with close clinician-engineer collaboration. This review underscores the need for a multidisciplinary approach and provides a critical analysis of the available tools and their potential to advance long-term outcomes.
- 27 January 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 7 (2)
Open AccessUnderstanding the mechanisms of TAVI durability through computational modelling: a multidisciplinary review
As transcatheter aortic valve implantation (TAVI) expands to younger populations, durability has become a concern, requiring a lifetime rather than a single-procedure perspective. While clinical trials suggest comparable mid-term performance to surgical bioprostheses, data beyond 10 years remain limited, particularly for bicuspid valves, valve-in-valve procedures, and complex anatomies. Computational modelling combines patient anatomy and device design in computer-based simulations to study valve performance under physiological loading. Applied to TAVI, these models can reproduce implantation, evaluate mechanical stresses, and simulate blood flow, providing mechanistic insights into deterioration processes, including altered leaflet loading, stent deformation, and thrombosis-prone flow. Although these simulations do not directly assess durability, they use surrogate metrics linked with these mechanisms, helping identify factors that may influence longevity and guide design and procedural refinements. Clinically, modelling could support patient-specific planning and reintervention strategies, informing decisions across the valve-replacement pathway, an important consideration as younger patients are likely to undergo multiple lifetime procedures. Integrating these tools into pre-procedural planning may help anticipate challenges such as coronary access, annular geometry, and redo feasibility. However, current studies report elements of verification and field-level validation, but none complete a pre-specified, calibrated surrogate-to-outcome validation with uncertainty/sensitivity analysis; thus, durability predictions remain exploratory. Progress needs transparent verification, field checks vs. bench or imaging, surrogate calibration to data, outcome testing in independent cohorts, and routine uncertainty/sensitivity reporting, with close clinician-engineer collaboration. This review underscores the need for a multidisciplinary approach and provides a critical analysis of the available tools and their potential to advance long-term outcomes.
- Open Access
Clinical phenotypes in hypertension: a data-driven approach to risk stratification and outcome prediction
Background: Hypertension (HTN) is a major contributor to cardiovascular (CV) morbidity and mortality. Its heterogeneity complicates risk stratification. Unsupervised machine learning can identify risk profiles and refine preventative strategies. Objectives: This study applies clustering analysis to clinical data to identify HTN phenogroups and their link with CV abnormalities and outcomes. Methods: 14,840 UK Biobank participants with a diagnosis of HTN who underwent cardiovascular magnetic resonance (CMR) were analysed. K-means clustering was applied to 77 clinical variables. Associations with incident HF, atrial fibrillation (AF), atherosclerotic events, all-cause mortality, and major adverse cardiovascular events (MACE) were examined. Mediation analysis assessed the role of CV imaging metrics in risk stratification. Results: Three clusters emerged. Cluster 1, predominantly female with the most favourable metabolic profile, had the lowest risk. Cluster 2, predominantly male with the highest atherosclerosis burden, carried the greatest risk, particularly for AF and HF (Hazard ratio [HR] 1.80 and 1.85; p <0.005). This group showed the most severe cardiac remodelling, impaired cardiac mechanisms, and global left atrial (LA) dysfunction, approaching the HF myocardial substrate. Cluster 3 had an intermediate risk profile resembling metabolic syndrome, with moderate MACE risk and a higher susceptibility to AF (HR 1.30 and 1.61; p <0.05). While in cluster 2 the risk was largely mediated by LV remodelling, in cluster 3, its role was attenuated and more evenly balanced with LA dysfunction. Conclusions: Clustering analysis revealed distinct HTN phenotypes with unique clinical and imaging profiles, enhancing risk stratification and supporting more individualised treatment strategies.
Open AccessClinical phenotypes in hypertension: a data-driven approach to risk stratification and outcome prediction
Background: Hypertension (HTN) is a major contributor to cardiovascular (CV) morbidity and mortality. Its heterogeneity complicates risk stratification. Unsupervised machine learning can identify risk profiles and refine preventative strategies. Objectives: This study applies clustering analysis to clinical data to identify HTN phenogroups and their link with CV abnormalities and outcomes. Methods: 14,840 UK Biobank participants with a diagnosis of HTN who underwent cardiovascular magnetic resonance (CMR) were analysed. K-means clustering was applied to 77 clinical variables. Associations with incident HF, atrial fibrillation (AF), atherosclerotic events, all-cause mortality, and major adverse cardiovascular events (MACE) were examined. Mediation analysis assessed the role of CV imaging metrics in risk stratification. Results: Three clusters emerged. Cluster 1, predominantly female with the most favourable metabolic profile, had the lowest risk. Cluster 2, predominantly male with the highest atherosclerosis burden, carried the greatest risk, particularly for AF and HF (Hazard ratio [HR] 1.80 and 1.85; p <0.005). This group showed the most severe cardiac remodelling, impaired cardiac mechanisms, and global left atrial (LA) dysfunction, approaching the HF myocardial substrate. Cluster 3 had an intermediate risk profile resembling metabolic syndrome, with moderate MACE risk and a higher susceptibility to AF (HR 1.30 and 1.61; p <0.05). While in cluster 2 the risk was largely mediated by LV remodelling, in cluster 3, its role was attenuated and more evenly balanced with LA dysfunction. Conclusions: Clustering analysis revealed distinct HTN phenotypes with unique clinical and imaging profiles, enhancing risk stratification and supporting more individualised treatment strategies.
- Open Access
Myocardial Strain Measured by Cardiac Magnetic Resonance Predicts Cardiovascular Morbidity and Death
- 1 April 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 311 (1) , e232455
Left Ventricular Trabeculations at Cardiac MRI: Reference Ranges and Association with Cardiovascular Risk Factors in UK Biobank
In an analysis applying automated segmentation to UK Biobank MRI scans, hypertension, higher body mass index, and higher physical activity level were associated with increased left ventricular trabeculations in healthy middle-aged White adults.
- 1 April 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 311 (1) , e232455
Left Ventricular Trabeculations at Cardiac MRI: Reference Ranges and Association with Cardiovascular Risk Factors in UK Biobank
In an analysis applying automated segmentation to UK Biobank MRI scans, hypertension, higher body mass index, and higher physical activity level were associated with increased left ventricular trabeculations in healthy middle-aged White adults.
- Open Access
- 22 November 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in TechRxiv
A Review of Evaluation Approaches for Explainable AI With Applications in Cardiology
Explainable artificial intelligence (XAI) elucidates the decision-making process of complex AI models and is important in building trust in model predictions. XAI explanations themselves require evaluation as to accuracy and reasonableness and in the context of use of the underlying AI model. This review details the evaluation of XAI in cardiac AI applications and has found that, of the studies examined, 37% evaluated XAI quality using literature results, 11% used clinicians as domain-experts, 11% used proxies or statistical analysis, with the remaining 43% not assessing the XAI used at all. We aim to inspire additional studies within healthcare, urging researchers not only to apply XAI methods but to systematically assess the resulting explanations, as a step towards developing trustworthy and safe models.
- 22 November 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in TechRxiv
Open AccessA Review of Evaluation Approaches for Explainable AI With Applications in Cardiology
Explainable artificial intelligence (XAI) elucidates the decision-making process of complex AI models and is important in building trust in model predictions. XAI explanations themselves require evaluation as to accuracy and reasonableness and in the context of use of the underlying AI model. This review details the evaluation of XAI in cardiac AI applications and has found that, of the studies examined, 37% evaluated XAI quality using literature results, 11% used clinicians as domain-experts, 11% used proxies or statistical analysis, with the remaining 43% not assessing the XAI used at all. We aim to inspire additional studies within healthcare, urging researchers not only to apply XAI methods but to systematically assess the resulting explanations, as a step towards developing trustworthy and safe models.
- Open Access
- 12 September 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 24 (10) , 1363-1373
Phenotyping left ventricular systolic dysfunction in asymptomatic individuals for improved risk stratification
Left ventricular systolic dysfunction (LSVD) is a heterogeneous condition with several factors influencing prognosis. Better phenotyping of asymptomatic individuals can inform preventative strategies. This study aims to explore the clinical phenotypes of LVSD in initially asymptomatic subjects and their association with clinical outcomes and cardiovascular abnormalities through multi-dimensional data clustering. Clustering analysis was performed on 60 clinically available variables from 1563 UK Biobank participants without pre-existing heart failure (HF) and with left ventricular ejection fraction (LVEF) < 50% on cardiovascular magnetic resonance (CMR) assessment. Risks of developing HF, other cardiovascular events, death, and a composite of major adverse cardiovascular events (MACE) associated with clusters were investigated. Cardiovascular imaging characteristics, not included in the clustering analysis, were also evaluated. Three distinct clusters were identified, differing considerably in lifestyle habits, cardiovascular risk factors, electrocardiographic parameters, and cardiometabolic profiles. A stepwise increase in risk profile was observed from Cluster 1 to Cluster 3, independent of traditional risk factors and LVEF. Compared with Cluster 1, the lowest risk subset, the risk of MACE ranged from 1.42 [95% confidence interval (CI): 1.03–1.96; P < 0.05] for Cluster 2 to 1.72 (95% CI: 1.36–2.35; P < 0.001) for Cluster 3. Cluster 3, the highest risk profile, had features of adverse cardiovascular imaging with the greatest LV re-modelling, myocardial dysfunction, and decrease in arterial compliance. Clustering of clinical variables identified three distinct risk profiles and clinical trajectories of LVSD amongst initially asymptomatic subjects. Improved characterization may facilitate tailored interventions based on the LVSD sub-type and improve clinical outcomes. Using clustering analysis of clinical data, we identified three distinct LVSD phenotypes amongst initially asymptomatic subjects (A, B). These phenotypes correlated with varying risks of adverse CV events (C) and were characterized by unique clinical features and CV imaging patterns (D). CV, cardiovascular; LVSD, left ventricular systolic dysfunction.
- 12 September 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 24 (10) , 1363-1373
Open AccessPhenotyping left ventricular systolic dysfunction in asymptomatic individuals for improved risk stratification
Left ventricular systolic dysfunction (LSVD) is a heterogeneous condition with several factors influencing prognosis. Better phenotyping of asymptomatic individuals can inform preventative strategies. This study aims to explore the clinical phenotypes of LVSD in initially asymptomatic subjects and their association with clinical outcomes and cardiovascular abnormalities through multi-dimensional data clustering. Clustering analysis was performed on 60 clinically available variables from 1563 UK Biobank participants without pre-existing heart failure (HF) and with left ventricular ejection fraction (LVEF) < 50% on cardiovascular magnetic resonance (CMR) assessment. Risks of developing HF, other cardiovascular events, death, and a composite of major adverse cardiovascular events (MACE) associated with clusters were investigated. Cardiovascular imaging characteristics, not included in the clustering analysis, were also evaluated. Three distinct clusters were identified, differing considerably in lifestyle habits, cardiovascular risk factors, electrocardiographic parameters, and cardiometabolic profiles. A stepwise increase in risk profile was observed from Cluster 1 to Cluster 3, independent of traditional risk factors and LVEF. Compared with Cluster 1, the lowest risk subset, the risk of MACE ranged from 1.42 [95% confidence interval (CI): 1.03–1.96; P < 0.05] for Cluster 2 to 1.72 (95% CI: 1.36–2.35; P < 0.001) for Cluster 3. Cluster 3, the highest risk profile, had features of adverse cardiovascular imaging with the greatest LV re-modelling, myocardial dysfunction, and decrease in arterial compliance. Clustering of clinical variables identified three distinct risk profiles and clinical trajectories of LVSD amongst initially asymptomatic subjects. Improved characterization may facilitate tailored interventions based on the LVSD sub-type and improve clinical outcomes. Using clustering analysis of clinical data, we identified three distinct LVSD phenotypes amongst initially asymptomatic subjects (A, B). These phenotypes correlated with varying risks of adverse CV events (C) and were characterized by unique clinical features and CV imaging patterns (D). CV, cardiovascular; LVSD, left ventricular systolic dysfunction.
- Open Access
- 12 April 2023
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 16 (7) , 905-915
Ischemic Heart Disease and Vascular Risk Factors Are Associated With Accelerated Brain Aging
- 12 April 2023
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 16 (7) , 905-915
Open AccessIschemic Heart Disease and Vascular Risk Factors Are Associated With Accelerated Brain Aging